Received Jul 3, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| VARZOS | ZOSTER (SHINGRIX) | GLAXOSMITHKLINE BIOLOGICALS | UNK | UNK | — |
| VARZOS | ZOSTER (SHINGRIX) | GLAXOSMITHKLINE BIOLOGICALS | UNK | UNK | — |
Double dose of Shingrix by mistake; This non-serious case was reported by a consumer via interactive digital media and described the occurrence of accidental overdose in a patient who received Herpes zoster (Shingrix) for prophylaxis. Co-suspect products included Herpes zoster (Shingrix) for prophylaxis. On an unknown date, the patient received Shingrix and Shingrix. On an unknown date, an unknown time after receiving Shingrix and Shingrix, the patient experienced accidental overdose (Verbatim: Double dose of Shingrix by mistake). The outcome of the accidental overdose was not applicable. Additional Information: GSK Receipt date:25-JUN-2025 This case was reported by a consumer via (shingrix GRC Chatbot) interactive digital media. The patient had been given two doses of Shingrix together by mistake, he/she wanted to know possible adverse effects, which led to accidental overdose.